FDA Warning Letters Emphasize CAPA, Design Issues

Article title
logo

The FDA focused its regulatory laser beam on the Midwest and overseas in the latest wave of medical device warning letters.

Enraf-Nonius B.V., a device maker based in the Netherlands but doing business in the U.S., was hit in several areas, including:

Failure establish and maintain device controls in relation to acceptable validation during a clinical trial, failure to set up procedures to determine whether device changes require validation or verification, and failure to document post-production design changes.

As is so often the case in FDA warning letters, CAPA again reared its head. In the July 5 letter, the device maker was charged with several alleged CAPA shortcomings. These include failure to establish a process that makes certain corrective actions are noted and take steps to prevent the issue from happening again, and failure to address illegible, missing and/or incorrect component codes.

Back here at home, Pennsylvania-based firm Lenfest Media Group was advised in a July 1 letter that its product claims lack FDA clearance or approval. Lenfest markets its WaxVec that it claims “gently draws dirt particles and moisture out of your ear quickly and safely.

warning640In Ohio, x-ray systems-manufacturer Meridian Medical Systems was hit with CAPA violations, and alleged design history violations, including:

  • A design plan for the project
  • Established or approved design inputs/outputs for the system
  • Verification or validation testing for the system
  • Design transfer
  • Risk management for the system
  • Design reviews

The firm was also warned for allegedly not having a handle on its suppliers, an issue that the FDA appears to be focusing on more and more. It could be, in part, because more and more domestic firms and outsourcing device manufacturing work overseas.

Completing our latest round-up, we travel to Turkey, where FDA issued a June 27 warning letter to Aygun Cerrahi Aletler A.S. Surgical Instruments Co., with charges of CAPA shortcomings and several other issues, including failure to establish and maintain procedures to ensure that the device design is correctly translated into production specifications, and failure to establish and maintain procedures for the identification, documentation, validation or where appropriate verification, review, and approval of design changes before their implementation.

 

Summary
FDA Warning Letters Emphasize CAPA, Design Issues
Article Name
FDA Warning Letters Emphasize CAPA, Design Issues
Description
The FDA focused its regulatory laser beam on the Midwest and overseas in the latest wave of medical device warning letters.
Author
Publisher Name
AssurX
Publisher Logo
article_logo
Showing 3 comments
  • Reply

    The link to the July 5 letter re ” the device maker was charged with several alleged CAPA shortcomings” must be incorrect as the linked letter contains no such complaint. I would appreciate seeing the FDA warning you alluded to.

    • Reply

      The link has been updated.

  • Reply

    Ah, I found it.

    “The firm was also warned for allegedly not having a handle on its suppliers, an issue that the FDA appears to be focusing on more and more.” ‘The firm’ here refers to Pennsylvania-based firm Lenfest Media Group in a July 1 letter, not the just mentioned Ohio x-ray systems-manufacturer Meridian Medical Systems.

    Sorry for the confusion I may have caused.

Leave a Reply

One Platform. Every Solution.
AssurX Quality + Compliance ManagementA single versatile system can improve quality, compliance and streamline workflow
Don't Miss A Post

Subscribe to our blog to receive an email when we publish new content.

Recommended posts
Recent Posts
Categories
One Platform. Every Solution.
AssurX Quality + Compliance ManagementA single versatile system can improve quality, compliance and streamline workflow